New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Strengthening Health Privacy Rules for Abortion Seekers and Providers
The Biden administration has updated Health Insurance Portability and Accountability Act (HIPAA) rules to safeguard patients seeking an abortion and providers involved in the procedure, according to Axios. These new rules aim to protect individuals from civil and criminal investigations, particularly in states with strict abortion laws. Although these measures are a step toward mitigating the impact of the Supreme Court's 2022 Dobbs v Jackson decision, challenges remain, with some states opposing the rule and potential legal battles on the horizon. Additionally, Congress is considering bipartisan privacy legislation to further protect individuals' reproductive health data.
Alzheimer Drug Faces Adoption Hurdles
Nine months after its US launch, lecanemab-irmb (Leqembi; Eisai and Biogen), the pioneering Alzheimer drug continues to face resistance from some doctors who believe that treating the disease is futile, according to Reuters. Despite its promising results, demanding requirements and concerns over efficacy, cost, and risks have hindered widespread adoption, reflecting therapeutic nihilism among health care providers. This slow uptake has underscored the deep-seated skepticism and practical barriers in revolutionizing Alzheimer disease treatment, despite the pressing need in a population of over 6 million affected Americans.
Balancing Nursing Home Staffing Mandates and Realities
The Biden administration's finalized nursing home staffing rules represent the most significant changes in federal oversight for these facilities in over 3 decades, according to Kaiser Health News. Aimed at rectifying perennial staffing shortages, exacerbated by the COVID-19 pandemic, the regulations mandate increased hiring of nurses and aides across nearly 15,000 nursing homes. Although hailed as progress by some, critics argue that the standards fall short of ideal levels, highlighting ongoing challenges in ensuring quality care for residents amid workforce shortages and financial strains in the industry.
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More
Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma
December 19th 2024Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.
Listen
ICYMI: Highlights From AMCP Nexus 2024
December 26th 2024Check out this year's top coverage from The Academy of Managed Care Pharmacy (AMCP) Nexus 2024 meeting, which included relevant topics in health care policy, novel pharmaceutical developments, financial considerations across multiple conditions, and more.
Read More